Top Markets
Coin of the day
Abpro Corporation Abpro Corporation

Abpro Corporation

ABP
株式のランク #39900
Abpro Holdings, Inc. is a biotechnology firm dedicated to creating... Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-100, designed to target breast, gastric, and colorectal cancers, and ABP-201, intended for the treatment of vascular diseases affecting the eye. The company has established strategic alliances with Abpro Bio Co. Ltd and NJCTTQ. Originally known as Abpro Corporation, the company officially changed its name to Abpro Holdings, Inc. in November 2024. Incorporated in 2004, Abpro Holdings, Inc. operates from its headquarters in Woburn, Massachusetts.
株価
$0.158
最終同期: 2026-04-06
時価総額
$302.92K
変化(1日)
16.18%
変化(1年)
-97.91%
US
取引 Abpro Corporation (ABP)

カテゴリー

Abpro Corporation(ABP)の配当利回りの履歴
Abpro Corporation(銘柄コード: ABP)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Abpro Corporation(ABP)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)